Results 181 to 188 of about 4,860 (188)

Repetitive18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients

Arthritis and Rheumatism, 2006
Daniel Blockmans
exaly  

Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysis

Arthritis and Rheumatism, 2007
Alfred D Mahr, Robert F Spiera, Michael P Lavalley   +2 more
exaly  

Efficacy of Biological-Targeted Treatments in Takayasu Arteritis

Circulation, 2015
Arsene Mekinian, Tristan Mirault, Jean-Emmanuel Kahn   +2 more
exaly  

Recent advances in our understanding of giant cell arteritis pathogenesis

Autoimmunity Reviews, 2017
Maxime Samson, Sylvain Audia, Bernard Bonnotte   +2 more
exaly  

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

Annals of the Rheumatic Diseases, 2018
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei   +2 more
exaly  

Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy

European Journal of Nuclear Medicine and Molecular Imaging, 2018
Berit Dalsgaard Nielsen, Lars Christian Gormsen, Kresten Krarup Keller   +2 more
exaly  

Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan

Circulation, 2015
exaly  

Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients

Arthritis and Rheumatism, 2007
exaly